Northwest Biotherapeutics Company

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Technology: Dendritic Cells
Industry: Dendritic Cells
Headquarters: Bethesda, Maryland, United States
Founded Date: 1998-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 1
Total Funding: 22447154
Estimated Revenue: Less than $1M
Last Funding Date: 2021-11-22
Last Funding Type: Post-IPO Debt

Visit Website
media@nwbio.com
http://twitter.com/NorthwestBio
Register and Claim Ownership